SMA is characterized by a loss of motor neurons with subsequent muscular atrophy and weakness, with its severity dependent on the allelic form related to mutations in SMN1 and the number of SMN2 copies, an SMN1 paralog that produces 10–15% of all functional SMN protein [3, 4]. Here, SMN2 is linked to muscular atrophy.